用于揭示 COVID-19 期间出现的心血管损伤的集体知识。
Collective Knowledge Used to Unveil Cardiovascular Injury Emerged during COVID-19.
机构信息
Department of Cardiovascular Medicine, Saga University, Saga 849-8501, Japan.
出版信息
Int J Mol Sci. 2022 May 6;23(9):5178. doi: 10.3390/ijms23095178.
Abstract
Two years have passed since the unprecedented breakout of the global pandemic of the coronavirus disease COVID-19, which began at the end of 2019 [...].
摘要
自 2019 年底爆发的冠状病毒病 COVID-19 全球大流行以来，已经过去了两年[...]。
相似文献
1
Collective Knowledge Used to Unveil Cardiovascular Injury Emerged during COVID-19.用于揭示 COVID-19 期间出现的心血管损伤的集体知识。
Int J Mol Sci. 2022 May 6;23(9):5178. doi: 10.3390/ijms23095178.
2
Cardiovascular Disease and SARS-CoV-2: the Role of Host Immune Response Versus Direct Viral Injury.心血管疾病与 SARS-CoV-2：宿主免疫反应与病毒直接损伤的作用。
Int J Mol Sci. 2020 Oct 30;21(21):8141. doi: 10.3390/ijms21218141.
3
COVID-19 Pandemic and the Impact on the Cardiovascular Disease Patient Care.新冠疫情及其对心血管疾病患者护理的影响。
Curr Cardiol Rev. 2020;16(3):173-177. doi: 10.2174/1573403X16666200621154842.
4
Management of acute cardiovascular events in patients with COVID-19.COVID-19 患者急性心血管事件的管理。
Rev Cardiovasc Med. 2020 Dec 30;21(4):577-581. doi: 10.31083/j.rcm.2020.04.140.
5
Collateral damage of a global pandemic: implications of COVID-19 for Australians with cardiovascular disease.全球大流行的附带损害：2019冠状病毒病对澳大利亚心血管疾病患者的影响
Intern Med J. 2020 Aug;50(8):1020-1021. doi: 10.1111/imj.14939.
6
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives.新型冠状病毒肺炎与心血管疾病：从基础机制到临床展望。
Nat Rev Cardiol. 2020 Sep;17(9):543-558. doi: 10.1038/s41569-020-0413-9. Epub 2020 Jul 20.
7
Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality.2019冠状病毒病（COVID-19）与心肌损伤及死亡率的关联
JAMA Cardiol. 2020 Jul 1;5(7):751-753. doi: 10.1001/jamacardio.2020.1105.
8
Unbiased COVID-19 Pandemic With Biased Global Recovery.全球复苏有失偏颇的无偏倚新冠疫情。
J Am Coll Cardiol. 2022 May 24;79(20):2018-2020. doi: 10.1016/j.jacc.2022.03.350.
9
Epidemiology, risk factors and prognosis of cardiovascular disease in the Coronavirus Disease 2019 (COVID-19) pandemic era: a systematic review.在 2019 年冠状病毒病（COVID-19）大流行时代，心血管疾病的流行病学、危险因素和预后：系统评价。
Rev Cardiovasc Med. 2022 Jan 17;23(1):28. doi: 10.31083/j.rcm2301028.
10
The Novel Coronavirus Disease (COVID-19) and Its Impact on Cardiovascular Disease.新型冠状病毒病（COVID-19）及其对心血管疾病的影响。
Cardiol Rev. 2020 Jul/Aug;28(4):163-176. doi: 10.1097/CRD.0000000000000317.
本文引用的文献
1
Mechanism of Blood-Heart-Barrier Leakage: Implications for COVID-19 Induced Cardiovascular Injury.血心屏障渗漏机制：对 COVID-19 引起的心血管损伤的影响。
Int J Mol Sci. 2021 Dec 17;22(24):13546. doi: 10.3390/ijms222413546.
2
Pathogenic Basis of Thromboinflammation and Endothelial Injury in COVID-19: Current Findings and Therapeutic Implications.新型冠状病毒肺炎血栓炎症与血管内皮损伤的发病基础：目前的研究结果与治疗意义
Int J Mol Sci. 2021 Nov 8;22(21):12081. doi: 10.3390/ijms222112081.
3
Tumor Necrosis Factor-Alpha Exacerbates Viral Entry in SARS-CoV2-Infected iPSC-Derived Cardiomyocytes.肿瘤坏死因子-α加剧 SARS-CoV2 感染的诱导多能干细胞衍生心肌细胞中的病毒进入。
Int J Mol Sci. 2021 Sep 13;22(18):9869. doi: 10.3390/ijms22189869.
4
Molecular Mechanisms of Palmitic Acid Augmentation in COVID-19 Pathologies.新冠病毒疾病中棕榈酸增加的分子机制
Int J Mol Sci. 2021 Jul 1;22(13):7127. doi: 10.3390/ijms22137127.
5
Pathophysiological Association of Endothelial Dysfunction with Fatal Outcome in COVID-19.内皮功能障碍与 COVID-19 致死结局的病理生理关联。
Int J Mol Sci. 2021 May 12;22(10):5131. doi: 10.3390/ijms22105131.
6
Cardiovascular Outcomes in the Acute Phase of COVID-19.COVID-19 急性期的心血管结局。
Int J Mol Sci. 2021 Apr 15;22(8):4071. doi: 10.3390/ijms22084071.
7
Vascular Endothelial Glycocalyx Damage in COVID-19.新型冠状病毒肺炎中的血管内皮糖萼损伤
Int J Mol Sci. 2020 Dec 19;21(24):9712. doi: 10.3390/ijms21249712.
8
Erythrocyte, Platelet, Serum Ferritin, and P-Selectin Pathophysiology Implicated in Severe Hypercoagulation and Vascular Complications in COVID-19.红细胞、血小板、血清铁蛋白和 P-选择素在 COVID-19 严重高凝和血管并发症中的病理生理学作用。
Int J Mol Sci. 2020 Nov 3;21(21):8234. doi: 10.3390/ijms21218234.
9
Emerging Mechanisms of Pulmonary Vasoconstriction in SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS) and Potential Therapeutic Targets.新型冠状病毒诱导的急性呼吸窘迫综合征（ARDS）中肺血管收缩的新兴机制和潜在治疗靶点。
Int J Mol Sci. 2020 Oct 29;21(21):8081. doi: 10.3390/ijms21218081.
10
Thrombosis risk associated with COVID-19 infection. A scoping review.与 COVID-19 感染相关的血栓形成风险。范围综述。
Thromb Res. 2020 Aug;192:152-160. doi: 10.1016/j.thromres.2020.05.039. Epub 2020 May 27.
Zotero 插件